Cardiol Therapeutics Inc. (CRDL) stock
Price, quality score, analyst targets, a 30-day Kronos AI forecast and a Shariah screen for Cardiol Therapeutics Inc., updated every trading day.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances)
Price
$1.17
+2.63% today
Market cap
$138M
Overall quality
54/100
Kronos AI 30-day
+12.0%
8 of 8 simulated paths end higher
Cardiol Therapeutics Inc. (CRDL) is a Health Care company in Biotechnology: Biological Products (No Diagnostic Substances), worth $138M. It trades at $1.17, up 2.63% today. Its overall quality score is 54 out of 100, ranked against the whole US market. 3 analysts' average target of $10.00 implies +754.7% from today's price. Kronos AI's 30-day forecast is +12.0% (8 of 8 simulated paths end higher).
Open the full interactive analysis →Charts, technical signals, DCF fair value and ownership
Analyst price targets
| Average target | $10.00 |
| Low – high | $9.00 – $11.00 |
| Analysts | 3 |
| Upside to average | +754.7% |
Kronos AI 30-day forecast
| Expected close | $1.28 (+12.0%) |
| Likely range | +9.2% … +31.1% |
| As of | 2026-10-27 |
8 of 8 simulated paths end higher.
Quality scores
| Profitability | 36 |
| Solvency | 86 |
| Growth | 41 |
| Overall | 54 |
| P/E | — |
Shariah screen
| Business activity | Passes |
| Debt and cash (AAOIFI 30%) | Not checked for this listing |
Automated screen of business activity and AAOIFI's 30% debt and cash limits. The 5% impermissible-income test is not applied. Check with a scholar before deciding.
Similar companies in Biotechnology: Biological Products (No Diagnostic Substances)
For information only, not investment advice. Prices updated: 2026-10-29.